Hexenoyl-hgrf 1-44 Powder
NDC Package 52416-107-01
Package Information
Hexenoyl-hgrf 1-44 powders is a medication used to reduce excess fat in the stomach area (abdomen) in people with HIV infection who have changes in the way their body fat is distributed. This formulation utilizes a powder delivery system. Marketed by Bachem Americas, Inc., this product is identified by NDC 52416-107.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 52416 - Bachem Americas, Inc.
- 52416-107 -
- 52416-107-01 - 105 g in 1 BOTTLE, GLASS
- 52416-107 -
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 52416-107-01 identifies a specific commercial package of 105 g in 1 bottle, glass of Hexenoyl-hgrf 1-44 (UNFINISHED drug), a bulk ingredient labeled by Bachem Americas, Inc.. This powder is formulated for use and contains tesamorelin acetate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bachem Americas, Inc. on November 10, 2010. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used to reduce excess fat in the stomach area (abdomen) in people with HIV infection who have changes in the way their body fat is distributed. Some HIV drugs may cause this side effect (increased fat in the upper back and stomach areas, decreased fat in the arms and legs). Tesamorelin works by causing your body to make more growth hormone. This medication should not be used for weight loss.
How is this Bachem Americas, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 52416010701. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.